Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INSM |
---|---|---|
09:32 ET | 69193 | 56.815 |
09:34 ET | 16830 | 57.07 |
09:36 ET | 15022 | 57.33 |
09:38 ET | 25388 | 57.24 |
09:39 ET | 10186 | 57.0707 |
09:41 ET | 11869 | 56.94 |
09:43 ET | 10816 | 56.78 |
09:45 ET | 71186 | 56.02 |
09:48 ET | 14424 | 56.515 |
09:50 ET | 15493 | 56.5092 |
09:52 ET | 14275 | 56.52 |
09:54 ET | 7585 | 56.39 |
09:56 ET | 20373 | 56.26 |
09:57 ET | 12839 | 56.415 |
09:59 ET | 9665 | 56.56 |
10:01 ET | 11747 | 56.38 |
10:03 ET | 17852 | 56.29 |
10:06 ET | 17722 | 56.12 |
10:08 ET | 25391 | 56.06 |
10:10 ET | 29527 | 56.15 |
10:12 ET | 37950 | 56.7 |
10:14 ET | 11224 | 56.4 |
10:15 ET | 18751 | 57.0219 |
10:17 ET | 22987 | 56.935 |
10:19 ET | 44819 | 56.34 |
10:21 ET | 5915 | 56.385 |
10:24 ET | 11485 | 56.36 |
10:26 ET | 15980 | 56.33 |
10:28 ET | 13076 | 56.33 |
10:30 ET | 10452 | 56.08 |
10:32 ET | 47704 | 56 |
10:33 ET | 10036 | 56.215 |
10:35 ET | 8613 | 56.08 |
10:37 ET | 14513 | 56.07 |
10:39 ET | 10318 | 56.1 |
10:42 ET | 9849 | 56.13 |
10:44 ET | 8773 | 56.07 |
10:46 ET | 57259 | 55.985 |
10:48 ET | 38203 | 55.4255 |
10:50 ET | 33832 | 55.3 |
10:51 ET | 21201 | 55.655 |
10:53 ET | 8003 | 55.68 |
10:55 ET | 40176 | 55.42 |
10:57 ET | 10330 | 55.44 |
11:00 ET | 23740 | 55.35 |
11:02 ET | 34994 | 55.525 |
11:04 ET | 23774 | 55.65 |
11:06 ET | 7485 | 55.525 |
11:08 ET | 19637 | 55.39 |
11:09 ET | 12008 | 55.31 |
11:11 ET | 60183 | 55.25 |
11:13 ET | 37519 | 55.38 |
11:15 ET | 13667 | 55.305 |
11:18 ET | 34308 | 55.24 |
11:20 ET | 24420 | 55.3 |
11:22 ET | 40961 | 55.265 |
11:24 ET | 23132 | 55.305 |
11:26 ET | 9392 | 55.36 |
11:27 ET | 8314 | 55.355 |
11:29 ET | 11830 | 55.25 |
11:31 ET | 7425 | 55.3 |
11:33 ET | 15137 | 55.34 |
11:36 ET | 2823 | 55.29 |
11:38 ET | 25370 | 55.28 |
11:40 ET | 29628 | 55.125 |
11:42 ET | 11216 | 55.14 |
11:44 ET | 10066 | 55.04 |
11:45 ET | 4105 | 55.09 |
11:47 ET | 9829 | 55.145 |
11:49 ET | 6671 | 55.15 |
11:51 ET | 11148 | 55.11 |
11:54 ET | 4641 | 55.045 |
11:56 ET | 20590 | 55.005 |
11:58 ET | 29411 | 55.02 |
12:00 ET | 4824 | 55.055 |
12:02 ET | 14979 | 55.035 |
12:03 ET | 3754 | 55.06 |
12:05 ET | 27599 | 55.135 |
12:07 ET | 5432 | 55.112 |
12:09 ET | 10806 | 55.095 |
12:12 ET | 19881 | 55.055 |
12:14 ET | 31615 | 55.035 |
12:16 ET | 56290 | 54.93 |
12:18 ET | 24990 | 54.5316 |
12:20 ET | 26764 | 54.69 |
12:21 ET | 16426 | 54.654 |
12:23 ET | 9574 | 54.845 |
12:25 ET | 4196 | 54.86 |
12:27 ET | 5882 | 54.92 |
12:30 ET | 20101 | 54.8 |
12:32 ET | 22701 | 54.805 |
12:34 ET | 6116 | 54.8 |
12:36 ET | 22153 | 55 |
12:38 ET | 18798 | 54.765 |
12:39 ET | 10219 | 54.6925 |
12:41 ET | 6608 | 54.735 |
12:43 ET | 21272 | 54.725 |
12:45 ET | 10390 | 54.735 |
12:48 ET | 35113 | 54.95 |
12:50 ET | 10500 | 54.82 |
12:52 ET | 22363 | 54.87 |
12:54 ET | 34149 | 55 |
12:56 ET | 67680 | 54.85 |
12:57 ET | 12971 | 54.895 |
12:59 ET | 10750 | 55.02 |
01:01 ET | 15674 | 55.03 |
01:03 ET | 74048 | 55.14 |
01:06 ET | 28012 | 55.175 |
01:08 ET | 20146 | 55.015 |
01:10 ET | 6200 | 55.04 |
01:12 ET | 36009 | 55.02 |
01:14 ET | 21993 | 55.005 |
01:15 ET | 10645 | 55.045 |
01:17 ET | 4819 | 55.065 |
01:19 ET | 16704 | 54.995 |
01:21 ET | 5087 | 55.04 |
01:24 ET | 9797 | 55.19 |
01:26 ET | 4400 | 55.09 |
01:28 ET | 25502 | 55.025 |
01:30 ET | 18313 | 55.015 |
01:32 ET | 52558 | 54.86 |
01:33 ET | 9168 | 54.96 |
01:35 ET | 7559 | 54.975 |
01:37 ET | 8797 | 54.935 |
01:39 ET | 8993 | 54.94 |
01:42 ET | 17892 | 54.8 |
01:44 ET | 4937 | 54.75 |
01:46 ET | 24856 | 54.41 |
01:48 ET | 9258 | 54.275 |
01:50 ET | 21849 | 54.24 |
01:51 ET | 7641 | 54.16 |
01:53 ET | 59458 | 53.99 |
01:55 ET | 36687 | 53.8 |
01:57 ET | 8130 | 53.7 |
02:00 ET | 60782 | 53.895 |
02:02 ET | 28714 | 54.025 |
02:04 ET | 51068 | 54.3 |
02:06 ET | 27218 | 54.37 |
02:08 ET | 10851 | 54.315 |
02:09 ET | 6293 | 54.41 |
02:11 ET | 8031 | 54.39 |
02:13 ET | 28006 | 54.395 |
02:15 ET | 9328 | 54.33 |
02:18 ET | 10220 | 54.4575 |
02:20 ET | 8374 | 54.48 |
02:22 ET | 3774 | 54.45 |
02:24 ET | 33412 | 54.79 |
02:26 ET | 26965 | 54.95 |
02:27 ET | 57439 | 54.93 |
02:29 ET | 13708 | 54.875 |
02:31 ET | 9793 | 54.77 |
02:33 ET | 6392 | 54.705 |
02:36 ET | 10121 | 54.68 |
02:38 ET | 48868 | 54.27 |
02:40 ET | 12987 | 54.13 |
02:42 ET | 7983 | 54.08 |
02:44 ET | 11934 | 54.28 |
02:45 ET | 21970 | 54.41 |
02:47 ET | 6189 | 54.215 |
02:49 ET | 13297 | 54.34 |
02:51 ET | 5123 | 54.2 |
02:54 ET | 25285 | 54.235 |
02:56 ET | 13893 | 54.335 |
02:58 ET | 8591 | 54.335 |
03:00 ET | 60962 | 54.4 |
03:02 ET | 3513 | 54.4 |
03:03 ET | 6441 | 54.305 |
03:05 ET | 10711 | 54.56 |
03:07 ET | 5072 | 54.64 |
03:09 ET | 14599 | 54.76 |
03:12 ET | 13328 | 54.56 |
03:14 ET | 9587 | 54.48 |
03:16 ET | 18754 | 54.525 |
03:18 ET | 22771 | 54.46 |
03:20 ET | 90651 | 54.44 |
03:21 ET | 10558 | 54.43 |
03:23 ET | 19284 | 54.67 |
03:25 ET | 20216 | 54.7 |
03:27 ET | 13477 | 54.88 |
03:30 ET | 20552 | 55 |
03:32 ET | 66503 | 54.94 |
03:34 ET | 30858 | 55 |
03:36 ET | 43546 | 55.125 |
03:38 ET | 22306 | 55.06 |
03:39 ET | 19030 | 54.98 |
03:41 ET | 27792 | 55.02 |
03:43 ET | 27360 | 55.05 |
03:45 ET | 24814 | 55.22 |
03:48 ET | 21214 | 55.135 |
03:50 ET | 27885 | 55.11 |
03:52 ET | 26185 | 55.02 |
03:54 ET | 55436 | 55.18 |
03:56 ET | 47775 | 55.0275 |
03:57 ET | 89604 | 55.02 |
03:59 ET | 60493 | 55.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Insmed Inc | 9.0B | -10.5x | --- |
Ascendis Pharma A/S | 7.9B | -14.0x | --- |
Legend Biotech Corp | 7.3B | -15.4x | --- |
Blueprint Medicines Corp | 6.6B | -21.9x | --- |
Intra-Cellular Therapies Inc | 7.1B | -58.3x | --- |
Vaxcyte Inc | 7.6B | -16.6x | --- |
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib and TPIP, as well as other early-stage research programs. Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), which is developing for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRSsNP). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil, which offers a differentiated product profile for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.0B |
---|---|
Revenue (TTM) | $315.5M |
Shares Outstanding | 163.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.12 |
EPS | $-5.23 |
Book Value | $-2.24 |
P/E Ratio | -10.5x |
Price/Sales (TTM) | 28.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -224.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.